PR (PR)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 4/9, Altman Z 2.4.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe company exhibits a distinct capital allocation profile characterized by an 8.1% ROIC and matching DuPont ROE, driven primarily by robust pricing power with an 18.5% net margin rather than operational efficiency or leverage; however, the low asset turnover of 0.28x suggests significant idle assets relative to sales volume. While the high gross margin of 41.0% indicates strong product differentiation, the stagnant revenue growth of just 1.3% YoY constrains top-line expansion potential. Financial integrity metrics present a mixed signal: a Piotroski F-Score of 4/9 reflects moderate financial health with limited score improvements over time, yet the Beneish M-Score of -2.64 strongly suggests low earnings manipulation risk and high fundamental quality from an accounting perspective.
Valuation currently trades at a 17.1x P/E multiple, which requires contextualization against historical norms and sector peers to determine if it represents a premium or discount for this specific growth trajectory. A DCF analysis implies a fair value of $16, suggesting the market price may be elevated relative to intrinsic worth calculated on current cash flow assumptions; notably, such models often embed optimistic long-term growth rates that appear inconsistent with the observed single-digit revenue expansion. This divergence between implied valuation multiples and sluggish top-line performance indicates the market is pricing in expectations of future acceleration that have not yet materialized in recent fiscal data.
Risk assessment is further complicated by significant insider activity, as $79 million in net selling over the last 90 days signals substantial distribution from corporate stakeholders. This aggressive internal divestiture contrasts with the low earnings manipulation risk flagged by the Beneish score, creating a nuanced picture where accounting reliability appears intact despite leadership's lack of confidence or liquidity needs. The combination of stagnant revenue growth, insider outflows, and a valuation that may exceed DCF-derived fair value warrants scrutiny regarding whether current pricing adequately compensates for these fundamental headwinds.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6.1% | 8.1% | 10.1% |
|---|---|---|---|
| 2% | $23 | $14 | $9 |
| 3% | $31 | $17 | $10 |
| 4% | $46 | $21 | $12 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=8.1%, terminal growth 3%. Fair value $17 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
⚠️ Dividend consumes >80% of FCF — sustainability risk.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XOP or IJJ, the fund manager is mechanically forced to buy or sell PR shares regardless of PR's individual fundamentals. We estimate $1.7B of passive capital is structurally linked to PR through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in PR to visualize passive redemption contagion across ETFs and collateral stocks.
If PR (PR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Exxon Mobil Corp. (XOM) as the most exposed collateral stock, sharing 1 ETFs with PR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 18 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
PR Ownership Dynamics
ETFs with Highest PR Exposure
Float lock-up computed from 18 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
PR Capital Efficiency
How efficiently does PR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
PR converts 15% of its EBITDA into free cash flow, a low conversion rate suggesting heavy reinvestment. This may indicate a growth phase (building capacity) or structural capital intensity. The 85% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 0.0% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 198,505 | $20.17 | $4.0M |
| 2026-05-07 | 162,039 | $21.21 | $3.4M |
| 2026-04-15 | 32,190 | $20.01 | $644,121.9 |
| 2026-04-13 | 3,060 | $20.66 | $63,219.6 |
| 2026-04-09 | 16,116 | $20.56 | $331,344.96 |
| 2026-04-06 | 404 | $21.18 | $8,556.72 |
| 2026-04-02 | 8,241 | $20.60 | $169,764.6 |
| 2026-03-31 | 628 | $21.49 | $13,495.72 |
| 2026-03-26 | 100 | $20.92 | $2,092 |
| 2026-03-20 | 851 | $19.97 | $16,994.47 |
| 2026-03-18 | 23,500 | $19.50 | $458,250 |
| 2026-03-17 | 84,700 | $19.23 | $1.6M |
| 2026-03-16 | 13,882 | $19.35 | $268,616.7 |
| 2026-03-13 | 1,896 | $19.07 | $36,156.72 |
| 2026-03-11 | 695 | $18.72 | $13,010.4 |
| 2026-02-23 | 69,000 | $17.96 | $1.2M |
| 2026-02-02 | 3,090 | $16.13 | $49,841.7 |
| 2026-01-30 | 2,692 | $16.05 | $43,206.6 |
| 2026-01-27 | 17 | $14.76 | $250.92 |
| 2026-01-16 | 950 | $14.32 | $13,604 |
| 2026-01-12 | 829,561 | $14.03 | $11.6M |
| 2025-12-30 | 100,639 | $13.92 | $1.4M |
| 2025-12-23 | 224 | $14.08 | $3,153.92 |
| 2025-12-11 | 9,234 | $15.01 | $138,602.34 |
| 2025-12-09 | 63 | $14.78 | $931.14 |
| 2025-12-08 | 358 | $14.92 | $5,341.36 |
| 2025-11-28 | 2,664 | $14.36 | $38,255.04 |
| 2025-11-25 | 73 | $13.98 | $1,020.54 |
| 2025-11-24 | 4,000 | $13.93 | $55,720 |
| 2025-11-20 | 387 | $14.02 | $5,425.74 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare PR to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.